AvroBio Current Cash

AvroBio (AVRO) currently reports a current cash of $240M as of March 2026. That compares with $310M in the prior-year period — down 22.6% year over year. Use the charts on this page to explore AvroBio's current cash history and peer comparisons.

AvroBio's current cash decreased from $310M to $240M — a 22.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AvroBio reported $240M in current cash as of March 2026. That compares with $310M in the prior-year period — down 22.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $240M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AvroBio, and consider following AVRO for alerts when major investors trade the stock.

AvroBio is classified in the Healthcare sector. On current cash, it currently shows $240M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVRO with unrelated industries.